Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: [email protected]. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Supplemental Recommendations About the Timing
of Influenza Vaccination, 2003--04 Season
In response to delays in production and distribution of
influenza vaccine during 2000, the Advisory
Committee on Immunization Practices (ACIP) recommended that first-available supplies of vaccine be administered to persons at increased risk for complications from influenza and to health-care workers. The committee also recommended that
mass vaccination campaigns for the 2000--01 season be delayed until the availability of supply was assured
(1,2). ACIP issued similar recommendations for the 2001--02 influenza season
(3) and has incorporated this prioritization into its
annual influenza recommendations (4).
To assist vaccinators in determining if administration of influenza vaccine should be prioritized because of anticipated delays or shortages, ACIP requested that ÐÇ¿ÕÓéÀÖ¹ÙÍø develop a process to assess the projected vaccine supply in advance of the influenza vaccination season. Each year, this process will be conducted collaboratively by ÐÇ¿ÕÓéÀÖ¹ÙÍø, the Food and Drug Administration, and the manufacturers who produce influenza vaccine.
On August 11, 2003, ÐÇ¿ÕÓéÀÖ¹ÙÍø determined that vaccine production for the 2003--04 influenza season is
proceeding satisfactorily and that projected production and distribution schedules will allow for sufficient supply of influenza vaccine during October and November. Therefore, influenza vaccination can proceed for all high-risk and healthy
persons, individually and through mass campaigns, as soon as vaccine is available.
Additional information about influenza and influenza vaccination is available from ÐÇ¿ÕÓéÀÖ¹ÙÍø at
http://www.cdc.gov/nip/flu/default.htm.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-ÐÇ¿ÕÓéÀÖ¹ÙÍø sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by ÐÇ¿ÕÓéÀÖ¹ÙÍø or the U.S.
Department of Health and Human Services. ÐÇ¿ÕÓéÀÖ¹ÙÍø is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
[email protected].
